Confluence Pharmaceuticals works is to advance all research in Autism and Fragile X Syndrome and bring to market a solution that treats core social and communication impairments. We understand the profound impact of being able to communicate and socially interact has on everyday life. We want to change the way people think about treating Fragile X and Autism….and how they will administer or direct therapies in the future.
This company will be presenting on Day 3 of DeepTechU 2022. View schedule >>